Harvey and Moloney have recently described the ability of passage lines of the Moloney strain of mouse leukemia virus to induce sarcomata in infant mice.1 In attempting to propagate the Moloney sarcoma virus (MSV) in mouse embryo tissue culture, we found that it produced foci of altered cells. This report describes an assay procedure based on focus formation, and presents evidence that the focusforming particles are defective.
Materials and Methods.-Viruses: MSV virus was given to Dr. A. C. Allison by Dr. Moloney, and passed in infant CDF1 mice; we received the virus from Dr. Allison as extracts of tumor, liver, spleen, or salivary glands of tumorous mice. The virus used for most experiments was a tissue-culture passage line originating with the liver extract. Pools were made by infecting flask (75 sq cm, Falcon Plastic Co.) cultures of NIH Swiss mouse embryo with 1-2 ml of undiluted virus, harvesting at 9-10 days when cellular alteration was widespread, and sonicating the cells and adding them to the culture fluid. Virus was stored at -60'C.
Moloney leukemia virus was used at 7th or 8th mouse embryo tissue culture passage. 2 Tissue cultures: Secondary cultures of NIH Swiss whole mouse embryo cultures were prepared as described previously. 2 A continuous line (CL-1) of BALB/c mouse embryo cells was used for the majority of focus assays. This line was established in our laboratory by serial trypsinization passage of control cultures, and was used in these studies at the 39th to 50th passage. The cells are of relatively uniform epithelioid appearance, and grow as a uniform monolayer. At passage 31, subcutaneous injection of 106 cells into newborn BALB/c mice did not result in tumor formation.
Growth medium for all cultures was Eagle's minimal essential medium with glutamine, penicillin, and streptomycin (EMEM) with 10% unheated fetal bovine serum. This medium was also used for maintenance of cultures used for production of leukemia virus pools and for complement fixing (CF) antigen induction assays. Maintenance medium for MSV focus assays and virus production was 5% heated (560, 30 min) calf serum in EMEM.
Cultures for focus assays were grown in 50-mm plastic Petri dishes (Falcon Plastics, Los Angeles) held in humidified 5% CO2 atmosphere. Cultures were planted with 350,000 cells, and were used on the day after planting; at this time the cell sheet was not fully formed but there were areas of beginning confluence. The cell sheet was rinsed once with EMEM, and 4 ml of maintenance medium was added. Virus dilutions were made in 20% veal infusion broth in EMEM; 0.4 ml virus dilution was added per plate. Fluids were changed at 2-3-day intervals. Agar overlay was not used; consequently, foci were counted as early as possible, usually on the fifth day. Counting was done with a dissecting microscope with lighting adjusted so that the foci stood out as silvery areas against a dark background.
Virus titrations using CF antigen induction as the endpoint were done in NIH mouse embryo cultures as described previously.2
Antisera: Antisera to the Moloney and Friend viruses were prepared by immunization of rats with tissue-culture-grown virus. Weanling Osborne-Mendel rats were inoculated with tissue culture supernatant fluid (1.0 ml intraperitoneally and 0.5 ml intravenously) and bled 5-7 weeks later.
Sera were screened for CF and neutralizing antibody to the homologous virus, and high-titer sera were pooled. Control animals were immunized with fluid from uninoculated cultures. The Moloney and Friend antisera had homologous tissue culture neutralization titers of 1:80 and 1: 40, respectively, and titered 1:80 or greater in CF tests against tissue-culture cell antigens of homologous and heterologous mouse leukemia viruses. There was no CF reactivity when 1:10 serum dilutions were tested against control antigens.
Results.-Production of foci by MSV: The tumor and organ extracts of 1ISV-infected mice induced focal lesions in both NIH embryo and CL-1 cultures, and culture fluids and cell extracts produced similar changes on serial passage. The foci contained two types of altered cells: round cells (in CL-1 cultures these cells tended to be ovoid) and spindle cells which differed from normal fibroblasts in being longer and thinner and having more distinct outlines (Fig. 1) . Foci became observable within 3-5 days, enlarged somewhat over the next few days, and then remained relatively stationary. The morphology of the foci suggested some piling up of cells, but crisscrossing of cells was not a conspicuous feature. There was generally no necrosis or cell loss. Satellite foci appeared around previous foci at 7-10 days. No evidence of contamination by other mouse viruses was found. Antigens prepared from infected cultures or tumors did not react with potent antisera to polyoma, K, mouse hepatitis, mouse adenovirus, Reo-3, LCM, or mouse salivary gland virus or with sera of hamsters carrying tumors induced by Ad. 12, SV40, or the Schmidt-Ruppin strain of Rous virus. Also, weanling mice inoculated with tissue-culture virus did not develop antibody to the above-mentioned mouse viruses or to PVM or Theiler's GDVII. Pleuropneumonia-like organisms could not be cultured from infected cultures, and achromycin had no inhibitory effect on focus production.
Requirement for helper virus for focus production: Titrations of most MSV preparations by focus formation showed a complex dose-response relationship. In the lower dilutions the number of foci fell proportionally to the dilution factor, but with further dilution the number fell with the square of the dilution factor, indicating a requirement for dual infection for focus induction (Fig. 2) .
MSV preparations consist of a mixture of sarcomagenic and leukemogenic particles, as determined by mouse pathogenicity1 and tissue culture studies. Limiting titration dilutions of tissue-culture-grown MSV yielded Moloney virus, as detected by antigen induction in tissue cultures, but no focus-forming particles. For example, an MSV tissue culture pool titered 103.4 focus-forming units per 0.4 ml and 105.6 ID50 per 0.4 ml by antigen induction; undiluted fluids from the plates inoculated with 10-4 and 10-5 dilutions induced antigen, but no foci, on passage to CL-1 and NIH embryo cultures. This suggested that the two-hit dose response of focus production represented a requirement for dual infection by a defective particle containing the genetic information for focus formation (defective in the sense that a single such particle cannot initiate a focus) and a conventional Moloney virus par-PROC. N. A. S. ticle. This was readily confirmed by titrating MSV in the presence of excess Moloney virus; dilutions of MSV tissue culture virus or tumor extract were added to CL-1 plate cultures, half of which were simultaneously inoculated with 106.1 TCID50 of tissue-culture-grown Moloney virus (Fig. 2) . It is seen that addition of the helper virus markedly increased the number of foci, and converted the two-hit dose-response curve to a one-hit curve. This phenomenon was repeatedly observed in CL-1 cultures and secondary cultures of BALB/c mouse embryo, but less frequently in NIH embryo cultures, the dose-response relationship in these cultures often showing the characteristic two-hit pattern whether or not helper virus was added. The helper effect was found with tissue-culture-grown Moloney virus from a variety of sources, and with Rauscher virus, but not with tissue-culture-grown virus of other strains, including the Gross passage A, WM1-B, and Friend strains, and field strains from AKR, C58, and C3H mice (see Table 1 ). Though not significant in the test shown in Table 1 , these other strains often reduced focus production, presumably by interference. dilution (multiplicity about 0.6 TCID5o per cell) but the increase was generally not as great as with undiluted virus. A 10-2 dilution gave no helper effect. These findings confirm that the helper effect was due to virus particles rather than some other factor in the medium.
The requirement for high dosage of helper may explain the failure of some of the other strains to produce helper effect, since most strains do not attain as high titer as Moloney virus.
Discussion.-The similarity of the present findings to Rous virus (Bryan strain) infection is striking. In both systems a sarcomagenic variant of a noncytopathic, leukemogenic RNA virus induces focal areas of morphologically altered cells in tissue culture, and the focus-forming particles are always found in the presence of an excess of non-focus-forming virus.e 5 In both cases the excess nonfocus-forming virus can be detected by induction of CF antigen.2' 6 The two systems are also analogous in the defectiveness of the focus-forming particles and the participation of helper virus, but there appears to be a fundamental difference in the type of defectiveness. A single Rous particle can initiate focus formation,4 the helper being required for formation of infectious virus;5 in the MSV system, helper is required for focus formation and presumably also for virus production. The need for production of virus for focus production was borne out by the observation that antiserum added at 24 hr suppressed focus formation. Another difference from the Rous system, of little theoretical importance but significant from the technical standpoint, is the higher ratio of helper to focus-forming particles in virus stocks. With MSV preparations the ratio is in the range of 102 to 103, rather than 101 as in the Rous system.7' 8 As a consequence, it might be expected that some MSV preparations would have sufficient helper that the two-hit requirement for focus formation would be obscured; some inldicationl of this has been seen with different pools of virus.
Whether the cells in MASV foci are capable of serial propagation, as are Roustransformed cells, has not been studied. The foci do not seem to form by cell proliferation alone, in view of the need for local spread of virus for focus production.
It is presumed that the focus-forming virus in MSV is a mutant of the Moloney leukemia virus, but this is not at all certain. It is conceivable that it is an unrelated virus acting synergistically with Moloney virus to induce foci. The neutralization of focus induction with anti-Moloney serum could represent elimination of the helper virus without a direct effect on the focus-formers. Since we have not obtained helper effect with antigenically distinct mouse leukemia virus strains, it was not possible to test this by addition of antigenically distinct helper to a neutral mixture of MSV plus Moloney antiserum. However, the harvest (cell sonicate plus fluid, at 8 days) of a plate inoculated with such a neutral mixture did not induce foci, in the presence of added helper; this suggests that the focus-forming virus is neutralized by the anti-Moloney serum, but this inference is not valid if M\ioloney virus is required for its replication.
Another possibility is that the focus-forming particles are defective hybrids of Moloney and another virus, analogous to the adenovirus-SV40 hybrids.9 No serologic or cultural evidence of a contaminating mouse virus was found, but this does not rule out the possibility of a hybrid.
The accentuation of focus formation by addition of Moloney virus as helper raises the possibility that sarcoma formation in vivo might have a similar two-hit requirement and that addition of Moloney virus would increase the sarcoma induction titer. Preliminary experiments indicate that this is the case.
Summary.-Moloney sarcoma virus (MSV) induces focal areas of altered cells in mouse tissue cultures. MSV preparations consist of a mixture of focus-forming and non-focus-forming particles, with the latter in large excess. Focus production generally follows a two-hit dose response curve, but when MSV is titrated in the presence of excess Moloney leukemia virus, the number of foci is increased, and the dose-response relation assumes a one-hit character. It is concluded that focus formation is initiated by a cell dually infected with focus-forming and non-focus-forming particles, the focus-formers being defective. Their defectiveness differs from that of Rous virus in that they require helper for initiation of a focus, while the Rous virus requires helper for virus growth but not for focus production.
